These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 17123277
21. Application of a continuous disease severity score to the OPTN liver waiting list. Edwards EB, Harper AM. Clin Transpl; 2001; ():19-24. PubMed ID: 12211782 [Abstract] [Full Text] [Related]
22. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease]. Sun J, Guo ZH, Lai TS, Tang YQ, Su L, Huo F, Wang SP, Pu MS, Wen Q. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907 [Abstract] [Full Text] [Related]
23. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. Aliment Pharmacol Ther; 2005 Jan 15; 21(2):169-77. PubMed ID: 15679767 [Abstract] [Full Text] [Related]
24. Liver transplantation in the era of model for end-stage liver disease. Wang VS, Saab S. Liver Int; 2004 Feb 15; 24(1):1-8. PubMed ID: 15101994 [Abstract] [Full Text] [Related]
25. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Freeman RB. Liver Transpl; 2004 Oct 15; 10(10 Suppl 2):S2-3. PubMed ID: 15382218 [No Abstract] [Full Text] [Related]
26. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep 15; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
27. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Yoo HY, Thuluvath PJ. Liver Int; 2005 Jun 15; 25(3):536-41. PubMed ID: 15910490 [Abstract] [Full Text] [Related]
28. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD. Liver Int; 2006 Feb 15; 26(1):55-61. PubMed ID: 16420510 [Abstract] [Full Text] [Related]
29. Acute renal failure after liver transplantation in MELD era. Faenza S, Bernardi E, Cimatti M, Dante A, Mancini E, Miklosova Z, Piraccini E, Pierucci E, Riganello I, Spedicato S, Zanoni A, Santoro A. Transplant Proc; 2007 Feb 15; 39(6):1945-6. PubMed ID: 17692661 [Abstract] [Full Text] [Related]
30. MELD-based allocation scheme for liver transplantation in Israel. Onaca N, Mor E. Isr Med Assoc J; 2006 Sep 15; 8(9):651-2. PubMed ID: 17058421 [No Abstract] [Full Text] [Related]
31. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Liver Transpl; 2007 Nov 15; 13(11):1564-9. PubMed ID: 17969210 [Abstract] [Full Text] [Related]
32. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Gitto S, Lorenzini S, Biselli M, Conti F, Andreone P, Bernardi M. Dig Liver Dis; 2009 Oct 15; 41(10):700-6. PubMed ID: 19502118 [Abstract] [Full Text] [Related]
33. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562 [Abstract] [Full Text] [Related]
34. Abdominal imaging and intervention in liver transplantation. Almusa O, Federle MP. Liver Transpl; 2006 Feb 15; 12(2):184-93. PubMed ID: 16447193 [Abstract] [Full Text] [Related]
35. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR. Liver Transpl; 2009 Oct 15; 15(10):1270-7. PubMed ID: 19790155 [Abstract] [Full Text] [Related]
36. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality. Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R. Isr Med Assoc J; 2006 Sep 15; 8(9):605-9. PubMed ID: 17058408 [Abstract] [Full Text] [Related]
37. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center. Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U. Transplant Proc; 2008 Sep 15; 40(6):1903-5. PubMed ID: 18675084 [Abstract] [Full Text] [Related]
38. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Cuomo O, Perrella A, Arenga G. Transplant Proc; 2008 Sep 15; 40(6):1906-9. PubMed ID: 18675085 [Abstract] [Full Text] [Related]
39. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, Wekerle T, Berlakovich GA, Steininger R, Muehlbacher F. Transplantation; 2007 Mar 15; 83(5):588-92. PubMed ID: 17353779 [Abstract] [Full Text] [Related]
40. MELD-based liver allocation: who is underserved? Biggins SW, Bambha K. Semin Liver Dis; 2006 Aug 15; 26(3):211-20. PubMed ID: 16850370 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]